High level expression in soluble form, one step purification, and characterization of the DNA binding domain of MEF-2C

Protein Expression and Purification
D Meierhans, R K Allemann

Abstract

Members of the MEF-2 family of transcription factors act as coregulators of basic helix-loop-helix (BHLH) proteins in the control of lineage specific gene expression in many cell types through direct interaction between the respective DNA binding domains. To make possible a thorough biochemical, biophysical, and structural characterization of the properties of myocyte enhancer factor (MEF) proteins and of their interactions with BHLH-proteins, a simple system for high level expression and rapid purification of myocyte enhancer factor-2C (MEF-2C) was developed. A T7 expression system was used to produce in high yield in Escherichia coli an N-terminal fragment of MEF-2C comprising both the MADS box and the MEF domain. Purification by a single round of cation-exchange chromatography on a Resource-S HPLC column at elevated pH afforded an essentially pure protein. Recombinant MEF-2C (1-117) bound with high affinity to the MEF consensus DNA binding site (CTATAAATAG). Mutations in this sequence that replaced adenines with thymine or vice versa did not significantly alter the affinity for MEF-2C(1-117). The introduction of G-C pairs into the core of the MEF-site, however, dramatically increased the concentration of MEF-2C(1-117) needed...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·B M PatersonW J Gehring
Jan 1, 1990·Methods in Enzymology·F W StudierJ W Dubendorff
Sep 1, 1990·Genes & Development·E N Olson
May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Jul 21, 1995·Journal of Molecular Biology·D B StarrD K Hawley
Aug 10, 1995·Nature·L PellegriniT J Richmond
Sep 5, 1995·Biochemistry·D MeierhanR K Allemann
Apr 1, 1995·European Journal of Biochemistry·P Shore, A D Sharrocks
Mar 1, 1994·Molecular and Cellular Biology·J F MartinE N Olson
Feb 16, 1996·Journal of Molecular Biology·R E DickersonM L Kopka
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J D Molkentin, E N Olson
Aug 1, 1996·Current Opinion in Genetics & Development·J D Molkentin, E N Olson
Dec 1, 1995·Neuron·L SommerD J Anderson
Apr 4, 1997·Cell·A Rawls, E N Olson
Feb 1, 1997·Protein Expression and Purification·S J Maleki, B K Hurlburt

❮ Previous
Next ❯

Citations

Sep 25, 1998·The Journal of Biological Chemistry·D Meierhans, R K Allemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.